Peptide Therapeutics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Peptide Therapeutics Market to 2027 - Global Analysis and Forecasts By Type ( Generic, Innovative ); Route of Administration ( Parenteral, Oral, Mucosal, Pulmonary, Others ); Synthesis Technology ( Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Technology ); Application ( Cancer, Cardiovascular Disorder, Metabolic Disorder, Respiratory Disorder, Pain, Dermatology )

Report Code: TIPRE00003793 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
Peptides are not only highly selective and efficacious but, also, relatively safe and well tolerated in human body. There are increased efforts has been taken in pharmaceutical research and development (R&D). In recent years, over 7000 naturally occurring peptides have been identified, which have crucial roles in human physiology, including actions as hormones, neurotransmitters, growth factors, ion channel ligands, or anti-infectives. Furthermore, peptide therapeutics are typically associated with lower production complexity compared with protein-based biopharmaceuticals and, therefore, the production costs are also lower, generally approaching those of small molecules.

MARKET DYNAMICS
The peptide therapeutics market is anticipated to grow in the forecast, owing to the factors such wide range of applications in medicine, growing peptide therapeutics research activities, increasing incidences of chronic diseases such as diabetes, obesity, and others in the market during the forecast period. However poor chemical and physical stability associated with the peptides and short half-life and fast elimination are the factors hampering the market growth.

MARKET SCOPE
The "Global Peptide Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the Biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of peptide therapeutics market with detailed market segmentation by type, route of administration, synthesis technology and application and geography. The global peptide therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading peptide therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global peptide therapeutics market is segmented on the basis of type, route of administration, synthesis technology and application. Based on type, the market is segmented as generic and innovative. On the basis of route of administration, the global peptide therapeutics market is segmented into parenteral, oral, mucosal, pulmonary, others. On the basis of synthesis technology the market is segmented into solid phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS), and hybrid technology. Based on application the market is segmented into cancer, cardiovascular disorder, metabolic disorder, respiratory disorder, pain, dermatology and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global peptide therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The peptide therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting peptide therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the peptide therapeutics market in these regions.

MARKET PLAYERS
The reports cover key developments in the peptide therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from peptide therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for peptide therapeutics market in the global market. Below mentioned is the list of few companies engaged in the peptide therapeutics market.

The report also includes the profiles of key peptide therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Eli Lilly and Company;
  • Pfizer, Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • Lonza Inc.
  • Sanofi
  • Bristol-Myers Squibb (BMS)
  • AstraZeneca PLC
  • GlaxoSmithKline plc (GSK)
  • Novo Nordisk A/S
  • Amgen, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Peptide Therapeutics Market - By Type
1.3.2 Peptide Therapeutics Market - By Route of Administration
1.3.3 Peptide Therapeutics Market - By Synthesis Technology
1.3.4 Peptide Therapeutics Market - By Application
1.3.5 Peptide Therapeutics Market - By Region
1.3.5.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. PEPTIDE THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PEPTIDE THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PEPTIDE THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. PEPTIDE THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. PEPTIDE THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PEPTIDE THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. GENERIC
7.3.1. Overview
7.3.2. Generic Market Forecast and Analysis
7.4. INNOVATIVE
7.4.1. Overview
7.4.2. Innovative Market Forecast and Analysis
8. PEPTIDE THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. PARENTERAL
8.3.1. Overview
8.3.2. Parenteral Market Forecast and Analysis
8.4. ORAL
8.4.1. Overview
8.4.2. Oral Market Forecast and Analysis
8.5. MUCOSAL
8.5.1. Overview
8.5.2. Mucosal Market Forecast and Analysis
8.6. PULMONARY
8.6.1. Overview
8.6.2. Pulmonary Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. PEPTIDE THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - SYNTHESIS TECHNOLOGY
9.1. OVERVIEW
9.2. SYNTHESIS TECHNOLOGY MARKET FORECASTS AND ANALYSIS
9.3. SOLID PHASE PEPTIDE SYNTHESIS (SPPS)
9.3.1. Overview
9.3.2. Solid Phase Peptide Synthesis (SPPS) Market Forecast and Analysis
9.4. LIQUID PHASE PEPTIDE SYNTHESIS (LPPS)
9.4.1. Overview
9.4.2. Liquid Phase Peptide Synthesis (LPPS) Market Forecast and Analysis
9.5. HYBRID TECHNOLOGY
9.5.1. Overview
9.5.2. Hybrid Technology Market Forecast and Analysis
10. PEPTIDE THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
10.1. OVERVIEW
10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
10.3. CANCER
10.3.1. Overview
10.3.2. Cancer Market Forecast and Analysis
10.4. CARDIOVASCULAR DISORDER
10.4.1. Overview
10.4.2. Cardiovascular Disorder Market Forecast and Analysis
10.5. METABOLIC DISORDER
10.5.1. Overview
10.5.2. Metabolic Disorder Market Forecast and Analysis
10.6. RESPIRATORY DISORDER
10.6.1. Overview
10.6.2. Respiratory Disorder Market Forecast and Analysis
10.7. PAIN
10.7.1. Overview
10.7.2. Pain Market Forecast and Analysis
10.8. DERMATOLOGY
10.8.1. Overview
10.8.2. Dermatology Market Forecast and Analysis
10.9 OTHERS
10.8.1. Overview
10.8.2. Others Market Forecast and Analysis

11. PEPTIDE THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Peptide Therapeutics Market Overview
11.1.2 North America Peptide Therapeutics Market Forecasts and Analysis
11.1.3 North America Peptide Therapeutics Market Forecasts and Analysis - By Type
11.1.4 North America Peptide Therapeutics Market Forecasts and Analysis - By Route of Administration
11.1.5 North America Peptide Therapeutics Market Forecasts and Analysis - By Synthesis Technology
11.1.6 North America Peptide Therapeutics Market Forecasts and Analysis - By Application
11.1.7 North America Peptide Therapeutics Market Forecasts and Analysis - By Countries
11.1.7.1 United States Peptide Therapeutics Market
11.1.7.1.1 United States Peptide Therapeutics Market by Type
11.1.7.1.2 United States Peptide Therapeutics Market by Route of Administration
11.1.7.1.3 United States Peptide Therapeutics Market by Synthesis Technology
11.1.7.1.4 United States Peptide Therapeutics Market by Application
11.1.7.1.5 United States Peptide Therapeutics Market by Route of Administration
11.1.7.2 Canada Peptide Therapeutics Market
11.1.7.2.1 Canada Peptide Therapeutics Market by Type
11.1.7.2.2 Canada Peptide Therapeutics Market by Route of Administration
11.1.7.2.3 Canada Peptide Therapeutics Market by Synthesis Technology
11.1.7.2.4 Canada Peptide Therapeutics Market by Application
11.1.7.2.5 Canada Peptide Therapeutics Market by Route of Administration
11.1.7.3 Mexico Peptide Therapeutics Market
11.1.7.3.1 Mexico Peptide Therapeutics Market by Type
11.1.7.3.2 Mexico Peptide Therapeutics Market by Route of Administration
11.1.7.3.3 Mexico Peptide Therapeutics Market by Synthesis Technology
11.1.7.3.4 Mexico Peptide Therapeutics Market by Application
11.1.7.3.5 Mexico Peptide Therapeutics Market by Route of Administration
11.2. EUROPE
11.2.1 Europe Peptide Therapeutics Market Overview
11.2.2 Europe Peptide Therapeutics Market Forecasts and Analysis
11.2.3 Europe Peptide Therapeutics Market Forecasts and Analysis - By Type
11.2.4 Europe Peptide Therapeutics Market Forecasts and Analysis - By Route of Administration
11.2.5 Europe Peptide Therapeutics Market Forecasts and Analysis - By Synthesis Technology
11.2.6 Europe Peptide Therapeutics Market Forecasts and Analysis - By Application
11.2.7 Europe Peptide Therapeutics Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Peptide Therapeutics Market
11.2.7.1.1 Germany Peptide Therapeutics Market by Type
11.2.7.1.2 Germany Peptide Therapeutics Market by Route of Administration
11.2.7.1.3 Germany Peptide Therapeutics Market by Synthesis Technology
11.2.7.1.4 Germany Peptide Therapeutics Market by Application
11.2.7.2 France Peptide Therapeutics Market
11.2.7.2.1 France Peptide Therapeutics Market by Type
11.2.7.2.2 France Peptide Therapeutics Market by Route of Administration
11.2.7.2.3 France Peptide Therapeutics Market by Synthesis Technology
11.2.7.2.4 France Peptide Therapeutics Market by Application
11.2.7.3 Italy Peptide Therapeutics Market
11.2.7.3.1 Italy Peptide Therapeutics Market by Type
11.2.7.3.2 Italy Peptide Therapeutics Market by Route of Administration
11.2.8.3.3 Italy Peptide Therapeutics Market by Synthesis Technology
11.2.8.3.4 Italy Peptide Therapeutics Market by Application
11.2.7.4 Spain Peptide Therapeutics Market
11.2.7.4.1 Spain Peptide Therapeutics Market by Type
11.2.7.4.2 Spain Peptide Therapeutics Market by Route of Administration
11.2.7.4.3 Spain Peptide Therapeutics Market by Synthesis Technology
11.2.7.4.4 Spain Peptide Therapeutics Market by Application
11.2.7.5 United Kingdom Peptide Therapeutics Market
11.2.7.5.1 United Kingdom Peptide Therapeutics Market by Type
11.2.7.5.2 United Kingdom Peptide Therapeutics Market by Route of Administration
11.2.7.5.3 United Kingdom Peptide Therapeutics Market by Synthesis Technology
11.2.7.5.4 United Kingdom Peptide Therapeutics Market by Application
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Peptide Therapeutics Market Overview
11.3.2 Asia-Pacific Peptide Therapeutics Market Forecasts and Analysis
11.3.3 Asia-Pacific Peptide Therapeutics Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Peptide Therapeutics Market Forecasts and Analysis - By Route of Administration
11.3.5 Asia-Pacific Peptide Therapeutics Market Forecasts and Analysis - By Synthesis Technology
11.3.6 Asia-Pacific Peptide Therapeutics Market Forecasts and Analysis - By Application
11.3.7 Asia-Pacific Peptide Therapeutics Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Peptide Therapeutics Market
11.3.7.1.1 Australia Peptide Therapeutics Market by Type
11.3.7.1.2 Australia Peptide Therapeutics Market by Route of Administration
11.3.7.1.3 Australia Peptide Therapeutics Market by Synthesis Technology
11.3.7.1.4 Australia Peptide Therapeutics Market by Application
11.3.7.2 China Peptide Therapeutics Market
11.3.7.2.1 China Peptide Therapeutics Market by Type
11.3.7.2.2 China Peptide Therapeutics Market by Route of Administration
11.3.7.2.3 China Peptide Therapeutics Market by Synthesis Technology
11.3.7.2.4 China Peptide Therapeutics Market by Application
11.3.7.3 India Peptide Therapeutics Market
11.3.7.3.1 India Peptide Therapeutics Market by Type
11.3.7.3.2 India Peptide Therapeutics Market by Route of Administration
11.3.7.3.3 India Peptide Therapeutics Market by Synthesis Technology
11.3.7.3.4 India Peptide Therapeutics Market by Application
11.3.7.4 Japan Peptide Therapeutics Market
11.3.7.4.1 Japan Peptide Therapeutics Market by Type
11.3.7.4.2 Japan Peptide Therapeutics Market by Route of Administration
11.3.7.4.3 Japan Peptide Therapeutics Market by Synthesis Technology
11.3.7.4.4 Japan Peptide Therapeutics Market by Application
11.3.7.5 South Korea Peptide Therapeutics Market
11.3.7.5.1 South Korea Peptide Therapeutics Market by Type
11.3.7.5.2 South Korea Peptide Therapeutics Market by Route of Administration
11.3.7.5.3 South Korea Peptide Therapeutics Market by Synthesis Technology
11.3.7.5.4 South Korea Peptide Therapeutics Market by Application
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Peptide Therapeutics Market Overview
11.4.2 Middle East and Africa Peptide Therapeutics Market Forecasts and Analysis
11.4.3 Middle East and Africa Peptide Therapeutics Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Peptide Therapeutics Market Forecasts and Analysis - By Route of Administration
11.4.5 Middle East and Africa Peptide Therapeutics Market Forecasts and Analysis - By Synthesis Technology
11.4.6 Middle East and Africa Peptide Therapeutics Market Forecasts and Analysis - By Application
11.4.7 Middle East and Africa Peptide Therapeutics Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Peptide Therapeutics Market
11.4.7.1.1 South Africa Peptide Therapeutics Market by Type
11.4.7.1.2 South Africa Peptide Therapeutics Market by Route of Administration
11.4.7.1.3 South Africa Peptide Therapeutics Market by Synthesis Technology
11.4.7.1.4 South Africa Peptide Therapeutics Market by Application
11.4.7.2 Saudi Arabia Peptide Therapeutics Market
11.4.7.2.1 Saudi Arabia Peptide Therapeutics Market by Type
11.4.7.2.2 Saudi Arabia Peptide Therapeutics Market by Route of Administration
11.4.7.2.3 Saudi Arabia Peptide Therapeutics Market by Synthesis Technology
11.4.7.2.4 Saudi Arabia Peptide Therapeutics Market by Application
11.4.7.3 U.A.E Peptide Therapeutics Market
11.4.7.3.1 U.A.E Peptide Therapeutics Market by Type
11.4.7.3.2 U.A.E Peptide Therapeutics Market by Route of Administration
11.4.7.3.3 U.A.E Peptide Therapeutics Market by Synthesis Technology
11.4.7.3.4 U.A.E Peptide Therapeutics Market by Application
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Peptide Therapeutics Market Overview
11.5.2 South and Central America Peptide Therapeutics Market Forecasts and Analysis
11.5.3 South and Central America Peptide Therapeutics Market Forecasts and Analysis - By Type
11.5.4 South and Central America Peptide Therapeutics Market Forecasts and Analysis - By Route of Administration
11.5.5 South and Central America Peptide Therapeutics Market Forecasts and Analysis - By Synthesis Technology
11.5.6 South and Central America Peptide Therapeutics Market Forecasts and Analysis - By Application
11.5.7 South and Central America Peptide Therapeutics Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Peptide Therapeutics Market
11.5.7.1.1 Brazil Peptide Therapeutics Market by Type
11.5.7.1.2 Brazil Peptide Therapeutics Market by Route of Administration
11.5.7.1.3 Brazil Peptide Therapeutics Market by Synthesis Technology
11.5.7.1.4 Brazil Peptide Therapeutics Market by Application
11.5.7.2 Argentina Peptide Therapeutics Market
11.5.7.2.1 Argentina Peptide Therapeutics Market by Type
11.5.7.2.2 Argentina Peptide Therapeutics Market by Route of Administration
11.5.7.2.3 Argentina Peptide Therapeutics Market by Synthesis Technology
11.5.7.2.4 Argentina Peptide Therapeutics Market by Application
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PEPTIDE THERAPEUTICS MARKET, KEY COMPANY PROFILES
13.1. ELI LILLY AND COMPANY
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. PFIZER, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. AMGEN, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. TEVA PHARMACEUTICALS INDUSTRIES LTD.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. LONZA INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. SANOFI
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BRISTOL-MYERS SQUIBB (BMS)
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ASTRAZENECA PLC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. GLAXOSMITHKLINE PLC (GSK)
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. NOVO NORDISK A/S
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Eli Lilly and Company
2. Pfizer, Inc.
3. Teva Pharmaceuticals Industries Ltd.
4. Lonza Inc.
5. Sanofi
6. Bristol-Myers Squibb (BMS)
7. AstraZeneca PLC
8. GlaxoSmithKline plc (GSK)
9. Novo Nordisk A/S
10. Amgen, Inc.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book